Literature DB >> 23256751

The gate that governs sulfotransferase selectivity.

Ian Cook1, Ting Wang, Steven C Almo, Jungwook Kim, Charles N Falany, Thomas S Leyh.   

Abstract

Human cytosolic sulfotransferases (SULTs) transfer the sulfuryl moiety (-SO(3)) from activated sulfate [3'-phosphoadenosine 5'-phosphosulfate (PAPS)] to the hydroxyls and primary amines of numerous metabolites, drugs, and xenobiotics. Receipt of the sulfuryl group often radically alters acceptor-target interactions. How these enzymes select particular substrates from the hundreds of candidates in a complex cytosol remains an important question. Recent work reveals PAPS binding causes SULT2A1 to undergo an isomerization that controls selectivity by constricting the opening through which acceptors must pass to enter the active site. The enzyme maintains an affinity for large substrates by isomerizing between the open and closed states with nucleotide bound. Here, the molecular basis of the nucleotide-induced closure is explored in equilibrium and nonequilibrium molecular dynamics simulations. The simulations predict that the active-site "cap," which covers both the nucleotide and acceptor binding sites, opens and closes in response to nucleotide. The cap subdivides into nucleotide and acceptor halves whose motions, while coupled, exhibit an independence that can explain the isomerization. In silico weakening of electrostatic interactions between the cap and base of the active site causes the acceptor half of the cap to open and close while the nucleotide lid remains shut. Simulations predict that SULT1A1, the most abundant SULT in human liver, will utilize a similar selection mechanism. This prediction is tested using fulvestrant, an anti-estrogen too large to pass through the closed pore, and estradiol, which is not restricted by closure. Equilibrium and pre-steady-state binding studies confirm that SULT1A1 undergoes a nucleotide-induced isomerzation that controls substrate selection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23256751      PMCID: PMC3549632          DOI: 10.1021/bi301492j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  The dimerization motif of cytosolic sulfotransferases.

Authors:  E V Petrotchenko; L C Pedersen; C H Borchers; K B Tomer; M Negishi
Journal:  FEBS Lett       Date:  2001-02-09       Impact factor: 4.124

2.  Virtual screening using protein-ligand docking: avoiding artificial enrichment.

Authors:  Marcel L Verdonk; Valerio Berdini; Michael J Hartshorn; Wijnand T M Mooij; Christopher W Murray; Richard D Taylor; Paul Watson
Journal:  J Chem Inf Comput Sci       Date:  2004 May-Jun

3.  Modification of liver cell volume by insulin and glucagon.

Authors:  C Hallbrucker; S vom Dahl; F Lang; W Gerok; D Häussinger
Journal:  Pflugers Arch       Date:  1991-06       Impact factor: 3.657

4.  Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study.

Authors:  T Okanoue; M Ohta; O Ou; K Kachi; K Kagawa; T Yuki; T Okuno; T Takino; S W French
Journal:  Lab Invest       Date:  1985-11       Impact factor: 5.662

5.  Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase.

Authors:  L C Pedersen; E V Petrotchenko; M Negishi
Journal:  FEBS Lett       Date:  2000-06-09       Impact factor: 4.124

6.  Acetaminophen and phenol: substrates for both a thermostable and a thermolabile form of human platelet phenol sulfotransferase.

Authors:  C Reiter; R M Weinshilboum
Journal:  J Pharmacol Exp Ther       Date:  1982-04       Impact factor: 4.030

7.  Sources and physiological significance of plasma dopamine sulfate.

Authors:  D S Goldstein; K J Swoboda; J M Miles; S W Coppack; A Aneman; C Holmes; I Lamensdorf; G Eisenhofer
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

8.  Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue.

Authors:  Walter Meinl; Ulrike Pabel; Mandy Osterloh-Quiroz; Jan G Hengstler; Hansruedi Glatt
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

9.  Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.

Authors:  Josie L Falany; Daniel E Pilloff; Thomas S Leyh; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

10.  The association of age with the activity of alcohol dehydrogenase in human liver.

Authors:  H A Wynne; P Wood; B Herd; P Wright; M D Rawlins; O F James
Journal:  Age Ageing       Date:  1992-11       Impact factor: 10.668

View more
  37 in total

1.  A high frequency missense SULT1B1 allelic variant (L145V) selectively expressed in African descendants exhibits altered kinetic properties.

Authors:  Zachary E Tibbs; Amber L Guidry; Josie L Falany; Susan A Kadlubar; Charles N Falany
Journal:  Xenobiotica       Date:  2017-02-05       Impact factor: 1.908

2.  Investigating the substrate binding mechanism of sulfotransferase 2A1 based on substrate tunnel analysis: a molecular dynamics simulation study.

Authors:  Li Zhao; Pupu Zhang; Shiyang Long; Linlin Wang; Hanyong Jin; Weiwei Han; Pu Tian
Journal:  J Mol Model       Date:  2016-07-08       Impact factor: 1.810

Review 3.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

4.  Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.

Authors:  Ian Cook; Ting Wang; Thomas S Leyh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

5.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

6.  Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Arch Biochem Biophys       Date:  2018-04-26       Impact factor: 4.013

Review 7.  Design and Interpretation of Human Sulfotransferase 1A1 Assays.

Authors:  Ting Wang; Ian Cook; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2015-12-09       Impact factor: 3.922

8.  Effect of SULT2B1 genetic polymorphisms on the sulfation of dehydroepiandrosterone and pregnenolone by SULT2B1b allozymes.

Authors:  Fatemah A Alherz; Amal A El Daibani; Maryam S Abunnaja; Ahsan F Bairam; Mohammed I Rasool; Yoichi Sakakibara; Masahito Suiko; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Mol Cell Endocrinol       Date:  2019-08-07       Impact factor: 4.102

9.  Testing the sulfotransferase molecular pore hypothesis.

Authors:  Ian Cook; Ting Wang; Steven C Almo; Jungwook Kim; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

10.  Modification of the catalytic function of human hydroxysteroid sulfotransferase hSULT2A1 by formation of disulfide bonds.

Authors:  Xiaoyan Qin; Lynn M Teesch; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2013-02-26       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.